Figure 5

Association of IFNL3/IFNL4 rs12979860 genotypes and baseline serum vitamin B₁₂ levels with a cut-off value of 570 ng/L with regard to SVR. This Box plot shows the SVR rates for antiviral therapy when both IFNL3/IFNL4 rs12979860 and baseline serum vitamin B₁₂ levels below or above the cut-off value of 570 ng/L were considered. The numbers in brackets represent: number of patients with SVR/total number of patients in that group.